Get 40% Off
🚨 Markets Are Down. Unlock Undervalued StocksFind Stocks Now

Oncolytics Biotech Inc (ONC)

Toronto
Currency in CAD
Disclaimer
1.44
+0.01(+0.70%)
Closed
ONC Scorecard
Earnings results expected in 11 days
Fair Value
Unlock Value
Day's Range
1.421.45
52 wk Range
1.204.49
Bid/Ask
1.44 / 1.45
Prev. Close
1.43
Open
1.42
Day's Range
1.42-1.45
52 wk Range
1.2-4.49
Volume
23,577
Average Vol. (3m)
82,731
1-Year Change
-10%
Shares Outstanding
75,419,768
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

People Also Watch

14.42
CFP
+0.77%
23.62
MFI
+1.03%
16.18
PSI
+1.06%
16.90
MATR
+1.93%
4.280
TCW
+0.94%
How do you feel today about ONC?
Vote to see community's results!
or

Oncolytics Biotech Inc Company Profile

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.